{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:53:07Z","timestamp":1780415587204,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic requires sensitive detection of the SARS-CoV-2 virus from samples to ensure accurate detection of infected patients, an essential component of effective national track and trace programs. Due to the scaling challenges of large sample numbers, sample pooling is an attractive solution to reduce both extraction and amplification reagent costs, if high sensitivity can be maintained. We demonstrate that the Erba Molecular ErbaMDx SARS-CoV-2 RT-PCR Kit (EM kit) delivers high sensitivity, achieving analytical detection of 5 copies\/reaction SARS-CoV-2 genomic RNA, and 200 copies\/mL SARS-CoV-2 inactivated virus spiked into nasopharyngeal swab (NP) samples and extracted through workflow. Furthermore, the EM Kit demonstrates high sensitivity in both pooled (1 in 5) and non-pooled NP samples when compared to an FDA Emergency Use Authorization approved assay, following published FDA guidelines. These findings demonstrate that the EM Kit is suitable for sample pooling, with minimal impact on assay performance. As the COVID-19 pandemic progresses, high sensitivity assays such as the EM Kit will have an important role in ensuring high throughput and sensitive testing using pooled samples can be maintained, delivering the most cost-effective sample extraction and amplification option for national test and trace programs.<\/jats:p>","DOI":"10.1038\/s41598-022-09254-1","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:04:56Z","timestamp":1648631096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development of a high sensitivity RT-PCR assay for detection of SARS-CoV-2 in individual and pooled nasopharyngeal samples"],"prefix":"10.1038","volume":"12","author":[{"given":"Harindi","family":"Jayakody","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lasota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Laverick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Tisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-4476","authenticated-orcid":false,"given":"Alistair D. S.","family":"Walsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"9254_CR1","unstructured":"who.int. Novel Coronavirus <https:\/\/www.who.int\/csr\/don\/12-january-2020-novel-coronavirus-china\/en\/> (2020)."},{"key":"9254_CR2","unstructured":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) <https:\/\/coronavirus.jhu.edu\/map.html> (2022)."},{"key":"9254_CR3","unstructured":"Transmission of SARS-CoV-2: implications for infection prevention precautions, <https:\/\/www.who.int\/news-room\/commentaries\/detail\/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions> (2020)."},{"key":"9254_CR4","unstructured":"Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing <https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/guidelines-clinical-specimens.html > (2021)."},{"key":"9254_CR5","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1039\/D1AY00947H","volume":"13","author":"H Jayakody","year":"2021","unstructured":"Jayakody, H., Kiddle, G., Perera, S., Tisi, L. & Leese, H. S. Molecular diagnostics in the era of COVID-19. Anal. Methods 13, 3744\u20133763. https:\/\/doi.org\/10.1039\/D1AY00947H (2021).","journal-title":"Anal. Methods"},{"key":"9254_CR6","unstructured":"Diagnostic testing for SARS-CoV-2, < https:\/\/www.who.int\/publications\/i\/item\/diagnostic-testing-for-sars-cov-2> (2020)."},{"key":"9254_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7326\/m20-4738","volume":"174","author":"L Caulley","year":"2021","unstructured":"Caulley, L. et al. Salivary detection of COVID-19. Ann. Intern. Med. 174, 131\u2013133. https:\/\/doi.org\/10.7326\/m20-4738 (2021).","journal-title":"Ann. Intern. Med."},{"key":"9254_CR8","unstructured":"Pooled Sample Testing and Screening Testing for COVID-19 < https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/pooled-sample-testing-and-screening-testing-covid-19> (2020)."},{"key":"9254_CR9","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2020.5445","volume":"323","author":"CA Hogan","year":"2020","unstructured":"Hogan, C. A., Sahoo, M. K. & Pinsky, B. A. Sample pooling as a strategy to detect community transmission of SARS-CoV-2. JAMA 323, 1967\u20131969. https:\/\/doi.org\/10.1001\/jama.2020.5445 (2020).","journal-title":"JAMA"},{"key":"9254_CR10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S2213-2600(20)30444-6","volume":"8","author":"A Fogarty","year":"2020","unstructured":"Fogarty, A., Joseph, A. & Shaw, D. Pooled saliva samples for COVID-19 surveillance programme. Lancet Respir. Med. 8, 1078\u20131080. https:\/\/doi.org\/10.1016\/S2213-2600(20)30444-6 (2020).","journal-title":"Lancet Respir. Med."},{"key":"9254_CR11","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.jcv.2020.104570","volume":"131","author":"GA Perchetti","year":"2020","unstructured":"Perchetti, G. A. et al. Pooling of SARS-CoV-2 samples to increase molecular testing throughput. J. Clin. Virol. 131, 104570\u2013104570. https:\/\/doi.org\/10.1016\/j.jcv.2020.104570 (2020).","journal-title":"J. Clin. Virol."},{"key":"9254_CR12","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/jmv.26632","volume":"93","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19. J. Med.. Virol. 93, 2805\u20132809. https:\/\/doi.org\/10.1002\/jmv.26632 (2021).","journal-title":"J. Med.. Virol."},{"key":"9254_CR13","unstructured":"COVID-19 testing strategies and objectives < https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/TestingStrategy_Objective-Sept-2020.pdf> (2020)."},{"key":"9254_CR14","doi-asserted-by":"publisher","first-page":"104439","DOI":"10.1016\/j.jcv.2020.104439","volume":"129","author":"S Kleiboeker","year":"2020","unstructured":"Kleiboeker, S. et al. SARS-CoV-2 viral load assessment in respiratory samples. J. Clin. Virol. 129, 104439\u2013104439. https:\/\/doi.org\/10.1016\/j.jcv.2020.104439 (2020).","journal-title":"J. Clin. Virol."},{"key":"9254_CR15","doi-asserted-by":"publisher","first-page":"e3042","DOI":"10.1093\/cid\/ciaa1382","volume":"73","author":"R Arnaout","year":"2021","unstructured":"Arnaout, R. et al. The limit of detection matters: The case for benchmarking severe acute respiratory syndrome coronavirus 2 testing. Clin. Infect. Dis. 73, e3042\u2013e3046. https:\/\/doi.org\/10.1093\/cid\/ciaa1382 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"9254_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243183","volume":"16","author":"Q Sun","year":"2021","unstructured":"Sun, Q. et al. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test. PLoS ONE 16, e0243183. https:\/\/doi.org\/10.1371\/journal.pone.0243183 (2021).","journal-title":"PLoS ONE"},{"key":"9254_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.micinf.2020.08.004","volume":"22","author":"D Jacot","year":"2020","unstructured":"Jacot, D., Greub, G., Jaton, K. & Opota, O. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses. Microbes Infect. 22, 617\u2013621. https:\/\/doi.org\/10.1016\/j.micinf.2020.08.004 (2020).","journal-title":"Microbes Infect."},{"key":"9254_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02593-20","author":"LK Kociolek","year":"2020","unstructured":"Kociolek, L. K. et al. Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.02593-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"9254_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/thoraxjnl-2020-215042","volume":"76","author":"SH Ra","year":"2021","unstructured":"Ra, S. H. et al. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection. Thorax 76, 61\u201363. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215042 (2021).","journal-title":"Thorax"},{"key":"9254_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2020.06.067","volume":"81","author":"KA Walsh","year":"2020","unstructured":"Walsh, K. A. et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J Infect 81, 357\u2013371. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.067 (2020).","journal-title":"J Infect"},{"key":"9254_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112454","volume":"165","author":"N Ravi","year":"2020","unstructured":"Ravi, N., Cortade, D. L., Ng, E. & Wang, S. X. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape. Biosens. Bioelectron 165, 112454. https:\/\/doi.org\/10.1016\/j.bios.2020.112454 (2020).","journal-title":"Biosens. Bioelectron"},{"key":"9254_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00743-20","author":"W Zhen","year":"2020","unstructured":"Zhen, W., Manji, R., Smith, E. & Berry, G. J. Comparison of four molecular in vitro diagnostic assays for the detection of SARS-CoV-2 in nasopharyngeal specimens. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.00743-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"9254_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ajcp\/aqaa064","volume":"153","author":"B Abdalhamid","year":"2020","unstructured":"Abdalhamid, B. et al. Assessment of specimen pooling to conserve SARS CoV-2 testing resources. Am. J. Clin. Pathol. 153, 715\u2013718. https:\/\/doi.org\/10.1093\/ajcp\/aqaa064 (2020).","journal-title":"Am. J. Clin. Pathol."},{"key":"9254_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf2823","author":"N Barak","year":"2021","unstructured":"Barak, N. et al. Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abf2823 (2021).","journal-title":"Sci. Transl. Med."},{"key":"9254_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238417","volume":"15","author":"KL Lim","year":"2020","unstructured":"Lim, K. L. et al. A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method. PLoS ONE 15, e0238417. https:\/\/doi.org\/10.1371\/journal.pone.0238417 (2020).","journal-title":"PLoS ONE"},{"key":"9254_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jiph.2020.01.307","volume":"13","author":"I Brukner","year":"2020","unstructured":"Brukner, I. et al. Maximizing confidence in a negative result: Quantitative sample adequacy control. J. Infect. Public Health 13, 991\u2013993. https:\/\/doi.org\/10.1016\/j.jiph.2020.01.307 (2020).","journal-title":"J. Infect. Public Health"},{"key":"9254_CR27","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/diagnostics11122373","volume":"11","author":"M Oughton","year":"2021","unstructured":"Oughton, M. et al. Importance of adequate qPCR controls in infection control. Diagnostics 11, 2373 (2021).","journal-title":"Diagnostics"},{"key":"9254_CR28","unstructured":"cdc.gov. Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic and Screening Testing, <https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/pooling-procedures.html> (2021)."},{"key":"9254_CR29","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1038\/s41598-021-91835-7","volume":"11","author":"MF Abasiyanik","year":"2021","unstructured":"Abasiyanik, M. F. et al. Sensitive detection and quantification of SARS-CoV-2 in saliva. Sci. Rep. 11, 12425. https:\/\/doi.org\/10.1038\/s41598-021-91835-7 (2021).","journal-title":"Sci. Rep."},{"key":"9254_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00776-20","author":"E Williams","year":"2020","unstructured":"Williams, E., Bond, K., Zhang, B., Putland, M. & Williamson, D. A. Saliva as a noninvasive specimen for detection of SARS-CoV-2. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/jcm.00776-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"9254_CR31","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3201\/eid2704.204199","volume":"27","author":"IM Ott","year":"2021","unstructured":"Ott, I. M. et al. Stability of SARS-CoV-2 RNA in nonsupplemented saliva. Emerg. Infect. Dis. 27, 1146\u20131150. https:\/\/doi.org\/10.3201\/eid2704.204199 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"9254_CR32","unstructured":"Considerations for the use of saliva as sample material for COVID-19 testing, < https:\/\/www.ecdc.europa.eu\/en\/publications-data\/considerations-use-saliva-sample-material-covid-19-testing> (2021)."},{"key":"9254_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.593491","author":"B Clerici","year":"2021","unstructured":"Clerici, B. et al. Sensitivity of SARS-CoV-2 detection with nasopharyngeal swabs. Front. Public Health https:\/\/doi.org\/10.3389\/fpubh.2020.593491 (2021).","journal-title":"Front. Public Health"},{"key":"9254_CR34","unstructured":"Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers, < https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/genetic-variants-sars-cov-2-may-lead-false-negative-results-molecular-tests-detection-sars-cov-2> (2021)."},{"key":"9254_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jinf.2021.01.013","volume":"82","author":"ESW Wilson-Davies","year":"2021","unstructured":"Wilson-Davies, E. S. W. et al. Concerning the OptiGene direct LAMP assay, and it\u2019s use in at-risk groups and hospital staff. J Infect 82, 282\u2013327. https:\/\/doi.org\/10.1016\/j.jinf.2021.01.013 (2021).","journal-title":"J Infect"},{"key":"9254_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.022","volume":"83","author":"A Stang","year":"2021","unstructured":"Stang, A. et al. The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population. J. Infect. 83, 237\u2013279. https:\/\/doi.org\/10.1016\/j.jinf.2021.05.022 (2021).","journal-title":"J. Infect."},{"key":"9254_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622. https:\/\/doi.org\/10.1373\/clinchem.2008.112797 (2009).","journal-title":"Clin. Chem."},{"key":"9254_CR38","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1373\/clinchem.2011.162958","volume":"57","author":"SA Bustin","year":"2011","unstructured":"Bustin, S. A. et al. Primer sequence disclosure: A clarification of the MIQE guidelines. Clin. Chem. 57, 919\u2013921. https:\/\/doi.org\/10.1373\/clinchem.2011.162958 (2011).","journal-title":"Clin. Chem."},{"key":"9254_CR39","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/clinchem\/hvaa214","volume":"66","author":"JF Huggett","year":"2020","unstructured":"Huggett, J. F. et al. Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2. Clin. Chem. 66, 1369\u20131372. https:\/\/doi.org\/10.1093\/clinchem\/hvaa214 (2020).","journal-title":"Clin. Chem."},{"key":"9254_CR40","unstructured":"Erba MDx SARS-CoV-2 RT-PCR Kit Instructions for Use. (2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:06:47Z","timestamp":1669338407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09254-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors (HJ, DR, CP, RB, TL, ML, LT, ADSW) are employed by Erba Molecular and did not receive any external funding. The funder Erba Molecular provided support in the form of salaries for the authors (HJ, DR, CP, RB, TL, ML, LT, ADSW). HSL declares no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5369"}}